158 related articles for article (PubMed ID: 31692239)
41. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Carotenuto M
Am J Hematol; 2000 Aug; 64(4):275-81. PubMed ID: 10911380
[TBL] [Abstract][Full Text] [Related]
42. Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia.
Miao Y; Fan L; Wu YJ; Xia Y; Qiao C; Wang Y; Wang L; Hong M; Zhu HY; Xu W; Li JY
Oncotarget; 2016 Mar; 7(12):13551-62. PubMed ID: 26910908
[TBL] [Abstract][Full Text] [Related]
43. CD 200 - A useful marker in chronic B lymphoprolipherative disorders.
Iova A; Vlădăreanu A; Bumbea H; Begu M; Vasile D; Andruş E
J Med Life; 2012; 5(Spec Issue):66-70. PubMed ID: 31803290
[No Abstract] [Full Text] [Related]
44. A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma.
Medd PG; Clark N; Leyden K; Turner S; Strefford JA; Butler C; Collins GP; Roberts DJ; Atoyebi W; Hatton CS
Cytometry B Clin Cytom; 2011; 80(4):230-7. PubMed ID: 21462308
[TBL] [Abstract][Full Text] [Related]
45. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
[TBL] [Abstract][Full Text] [Related]
46. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.
Mason EF; Pozdnyakova O; Li B; Dudley G; Dorfman DM
Am J Clin Pathol; 2017 Jul; 148(1):33-41. PubMed ID: 28575142
[TBL] [Abstract][Full Text] [Related]
47. Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders.
Venkataraman G; Aguhar C; Kreitman RJ; Yuan CM; Stetler-Stevenson M
Am J Clin Pathol; 2011 Oct; 136(4):625-30. PubMed ID: 21917686
[TBL] [Abstract][Full Text] [Related]
48. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ
Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079
[TBL] [Abstract][Full Text] [Related]
49. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL.
Barna G; Reiniger L; Tátrai P; Kopper L; Matolcsy A
Hematol Oncol; 2008 Sep; 26(3):167-70. PubMed ID: 18381689
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
Zhou K; Yi S; Yu Z; Li Z; Wang Y; Zou D; Qi J; Zhao Y; Qiu L
Leuk Lymphoma; 2012 Jun; 53(6):1155-61. PubMed ID: 22145958
[TBL] [Abstract][Full Text] [Related]
51. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients.
Morice WG; Kurtin PJ; Hodnefield JM; Shanafelt TD; Hoyer JD; Remstein ED; Hanson CA
Mayo Clin Proc; 2008 Jul; 83(7):776-85. PubMed ID: 18613994
[TBL] [Abstract][Full Text] [Related]
52. Expression of LEF1 in mantle cell lymphoma.
O'Malley DP; Lee JP; Bellizzi AM
Ann Diagn Pathol; 2017 Feb; 26():57-59. PubMed ID: 28038713
[TBL] [Abstract][Full Text] [Related]
53. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.
Hu Z; Sun Y; Schlette EJ; Tang G; Li S; Xu J; Yin CC; Young KH; Patel KP; Miranda RN; Goswami M; Wang M; Jorgensen JL; Medeiros LJ; Wang SA
Mod Pathol; 2018 Feb; 31(2):327-336. PubMed ID: 28984300
[TBL] [Abstract][Full Text] [Related]
54. [Immunophenotype analysis of leukemic mantle cell lymphoma].
Zhao M; Wu YJ; Fan L; Qiu HR; Yang H; Zhang ZH; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):371-6. PubMed ID: 23628035
[TBL] [Abstract][Full Text] [Related]
55. Independent diagnostic utility of CD20, CD200, CD43 and CD45 in chronic lymphocytic leukaemia.
Ramalingam TR; Mohanraj S; Muthu A; Prabhakar V; Ramakrishnan B; Vaidhyanathan L; Easow J; Raja T
Leuk Lymphoma; 2022 Feb; 63(2):377-384. PubMed ID: 34676804
[TBL] [Abstract][Full Text] [Related]
56. Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
Köhnke T; Wittmann VK; Bücklein VL; Lichtenegger F; Pasalic Z; Hiddemann W; Spiekermann K; Subklewe M
Br J Haematol; 2017 Nov; 179(3):480-487. PubMed ID: 28832948
[TBL] [Abstract][Full Text] [Related]
57. From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later.
Fang H; Medeiros LJ; Tang Z; Wang W; Ok CY; Patel KP; Khoury JD; Thakral B
Ann Diagn Pathol; 2021 Feb; 50():151649. PubMed ID: 33189964
[TBL] [Abstract][Full Text] [Related]
58. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
[TBL] [Abstract][Full Text] [Related]
59. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
60. Consistency of the Moreau CLL score.
Sorigue M; Sarrate E; Franch-Sarto M; Feliu E; Junca J
J Clin Lab Anal; 2018 Jun; 32(5):e22376. PubMed ID: 29282771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
